Showing results (31-40 of 253) with videos related to
Sort By:
Pageof 26
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2002
Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathyPeter Jacobsen, Steen Andersen, Kasper Rossing, et al.Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|August 10, 2005
The DIabetic REtinopathy Candesartan Trials (DIRECT) Programme: baseline characteristicsAnne Katrin Sjølie, Massimo Porta, Hans-Henrik Parving, et al.Journal of Diabetes and Its Complications|August 1, 2016
Renin angiotensin system blockade reduces urinary levels of soluble urokinase plasminogen activator receptor (suPAR) in patients with type 2 diabetesFrederik Persson, Simone Theilade, Jesper Eugen-Olsen, et al.Diabetes Research and Clinical Practice|February 24, 2009
Short-term oral treatment with the angiotensin II receptor antagonist losartan does not improve coronary vasomotor function in asymptomatic type 2 diabetes patientsAndreas Kjaer, Ulrik Sloth Kristoffersen, Lise Tarnow, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 31, 2002
Optimal dose of losartan for renoprotection in diabetic nephropathySteen Andersen, Peter Rossing, Tina R Juhl, et al.Kidney International|June 26, 2002
Effect of dietary protein restriction on prognosis in patients with diabetic nephropathyHenrik Post Hansen, Ellis Tauber-Lassen, Berit R Jensen, et al.Diabetes|May 5, 2009
Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort studyPeter Hovind, Peter Rossing, Lise Tarnow, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 8, 2003
Dipyridamole, cold pressor test, and demonstration of endothelial dysfunction: a PET study of myocardial perfusion in diabetesAndreas Kjaer, Christian Meyer, Flemming S Nielsen, et al.Kidney International|April 5, 2003
Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathyPeter Jacobsen, Steen Andersen, Kasper Rossing, et al.Diabetologia|June 3, 2019
Beneficial impact of intensified multifactorial intervention on risk of stroke: outcome of 21 years of follow-up in the randomised Steno-2 StudyPeter Gæde, Jens Oellgaard, Christina Kruuse, et al.Pageof 26